BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7016654)

  • 1. [Dilazep].
    Pirani R; Gruppillo P
    G Ital Cardiol; 1980; 10(10):1419-25. PubMed ID: 7016654
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of the clinical testing of a new coronary drug, Cormelian].
    Pollter J
    Fortschr Med; 1972 Apr; 90(10):399-404. PubMed ID: 4616888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].
    Parenti B; Selvaggi R
    Clin Ter; 1980 Jan; 92(2):155-63. PubMed ID: 7389275
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of dilazep on platelet thrombus formation and intimal thickening after mechanical injury of aorta in rabbit].
    Hayashi T
    Fukuoka Igaku Zasshi; 1988 Oct; 79(10):723-37. PubMed ID: 3248764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V; Barbaresi F; Plancher AC; Portioli I
    Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiodynamic changes induced with dilazep in chronic coronary insufficiency].
    Fogari R
    G Ital Cardiol; 1980; 10(12):1675-8. PubMed ID: 7250592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator.
    Saito D; Kusachi S; Nagashima H; Haraoka S
    Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noninvasive quantitative evaluation of cardiac reverse--effects of dilazep (adenosine like agent)].
    Morishita T; Arai C; Abe N; Takeuchi K; Hasegawa M; Takayama Y; Emori I; Yoshinori K
    Kokyu To Junkan; 1988 Jun; 36(6):675-9. PubMed ID: 3217607
    [No Abstract]   [Full Text] [Related]  

  • 10. Dilazep-induced reduction of ischemic necrosis in rats with coronary artery occlusion.
    Chiariello M; Brevetti G; Genovese A; Cataffo A; Ambrosio G; Condorelli M
    Int J Cardiol; 1983; 2(3-4):339-48. PubMed ID: 6840902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina].
    Romano M; De Caprio L; Scarafile P; Carlomagno A; Meccariello P; Condorelli M
    Minerva Cardioangiol; 1980; 28(7-8):489-94. PubMed ID: 7005711
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
    Pollter J; Schnitker J
    Med Welt; 1975 Oct; 26(44):2007-12. PubMed ID: 1186488
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study].
    Gillner H; Pollter J; Schnitker J; Sievers HG; Zylmann G
    Med Monatsschr; 1975 Feb; 29(2):82-7. PubMed ID: 1092990
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of a single high dose of dilazep by oral route.
    Ibba GV; Terrosu P; Franceschino V; Contini GM
    Int J Cardiol; 1986 Jun; 11(3):337-48. PubMed ID: 3721632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dilazep on hemoglobin-oxygen affinity in patients with ischemic heart disease.
    Koshu M; Sugimoto T; Terada Y; Uraoka T
    Jpn Heart J; 1985 Jul; 26(4):521-30. PubMed ID: 3903248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dilazep on regional myocardial blood flow during selective coronary hypotension.
    Fujii M; Kikuchi Y; Koyanagi S; Okamatsu S; Tomoike H; Nakamura M
    Arzneimittelforschung; 1981; 31(12):2067-71. PubMed ID: 7199300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H
    Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of dilazep on circulating platelet aggregation in diabetics].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O; Manotti C
    Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of albuminuria induced by dilazep administration in aminonucleoside nephrosis of rats.
    Nagase M; Kobayashi S; Sakakibara K; Honda N
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):385-91. PubMed ID: 4021200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.